Full-Time

Clinical Safety Associate

Safety Operations

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for diseases

Biotechnology
Healthcare

Compensation Overview

$105k - $120kAnnually

Mid, Senior

San Diego, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor's degree in a health-related area (RN/BSN) and 5 years in the pharmaceutical industry or CRO with at least 3 years in drug safety operations, pharmacovigilance, and/or a similar combination of education and experience
  • Strong working knowledge of FDA and international adverse event reporting regulations (ICH, EMA GPV, GCP etc.) and the ability to interpret and apply applicable regulations
  • Strong working knowledge of case management and Experience in using ARGUS or other safety databases. Experience with MedDRA/WHO for coding AEs, medical history, and concomitant medications
  • Experience with preparation with aggregate reports, preferably for investigational drugs (i.e., DSURs, IND Annual reports) or post-marketing products (i.e., PSUR/PBRER, PADERs)
  • Experience with quality assurance and compliance for drug safety
  • Self-motivated and detail oriented. Ability to multi-task and balance day-to-day drug safety operations and project work with tight timelines
  • Proficiency in Safety systems, ARGUS, MedDRA coding, standard desktop software programs (Word, Excel, Outlook)
  • Competency in obtaining, analyzing, and reporting safety data
  • Strong oral and written communication skills
  • Good organizational skills with the ability to perform multiple tasks efficiently and effectively while supporting team members
  • Motivated self-starter who can support teams and work independently
  • Strong interpersonal skills with the ability to professionally interact with all levels of personnel
Responsibilities
  • Participate in the standardized set-up of new safety projects, including development of Safety plans and documents, and set-up of safety systems
  • Ensure that reported SAE (and events of special interest to include pregnancy and overdose) event reports are received, tracked, evaluated, processed and distributed/submitted in an efficient and timely manner, and in compliance with regulations and Arrowhead Management Plans/SOPs
  • Generate appropriate queries to contact drug safety vendors (CROs) to complete and clarify SAE case information as needed and work with CRO to determine when cases are complete and ready to close
  • Ensure consistency in investigator causality assessment of SAE reports and source documentation for completeness, accuracy and legibility
  • Coordinate with vendors to ensure all internal/external timelines are met per PVA and ensure, potential issues are communicated, and resolution is achieved in a timely manner
  • Support activities related to implementing and maintaining the Safety Database, supporting ARGUS activities, Overseeing the Safety Vendors, and coordinating the Safety Reporting from Clinical Trials and Collaborators
  • Support other members of Safety Operations and Science personnel and ensure flawless execution of Safety and Pharmacovigilance processes
  • Vendor management, manage Safety Vendors, CRO and other external parties helping Arrowhead’s drug Safety and Pharmacovigilance
  • Facilitate the analysis of similar events for expedited safety reports occurring in pre-marketed clinical studies
  • Participate in tracking/monitoring of cases and other vendor or partner deliverables to ensure quality and timeliness of safety management activities, as well as adherence to regulatory and contractual obligations
  • Provide drug safety case management support to Safety medical monitors; assist in following up on queries for case reports, abnormal laboratory values, or any other relevant safety and medical data
  • Assist with the development and maintenance of departmental SOPs and other procedural documents
  • Support reviewing and monitoring of SAE/SUSAR case processing including, performing the secondary quality review for all case reports in the safety
  • Support the development and updating of Clinical Risk Management Plans for all clinical Prepare and update study-specific Safety Monitoring Plans as needed
  • Help in compiling safety data required for DSC and DSMB meetings for Arrowhead clinical studies
  • Monitor SAE reconciliation with the Arrowhead PV vendor and study CRO to ensure the reconciliation process is occurring for all clinical studies
  • Liaise with other company departments including, Clinical Operations, Quality, Regulatory, etc., and provide drug safety
  • Participate in inspection-readiness activities to included document and eTMF support.
  • Collaborate with Regulatory personal and CROs to communicate upcoming SAEs requiring expedited submissions to Regulatory Authorities, to include ad hoc reporting responsibilities form Arrowhead Safety.
  • Support the Manager of Safety Operations and Head of Clinical Safety in the review and development of written materials including clinical trial protocols, Informed Consent Forms, Case Report Forms, adverse event (AE)/ serious adverse event {SAE) reporting forms, Clinical Study Reports, and Investigator's Brochures (including Reference Safety Information determinations)
  • Informs Manager of safety related issues and potential trends and or signals arising from review of post-marketed safety data
  • Assist with safety database test configurations
  • Assist with review of cross-functional documents/plans (e.g., protocols, SAE Reconciliation Plans, etc.)
  • Participate in tracking/monitoring of cases and other vendor or partner deliverables to ensure quality and timeliness of safety management activities, as well as adherence to regulatory and contractual obligations.
  • Help in managing and updating safety surveillance procedures including signal detection review processes and monitoring abnormal trending of adverse events and laboratory results
  • Support monitoring safety surveillance for Arrowhead's clinical development products to ensure corporate compliance with national and international adverse event reporting requirements
  • Maintenance of Arrowhead safety operations documentation (e.g., safety case files), and management of the Safety Mailboxes.
  • Help in quality assurance activities, including deviation reports and generating necessary CAPA to ensure Arrowhead is meeting all safety compliance requirements
  • Participate in the production and validation of appropriate safety data output from the external or internal safety database for required safety deliverables (e.g. DSUR, IB, ad hoc analyses etc.).
  • Manage Arrowhead's QMS for safety/Pharmacovigilance procedures
  • Participate in and help with preparation for regulatory inspections including a compiling of material relating to safety/pharmacovigilance reports and activities
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure that the target genes are significantly reduced in activity. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. The goal of Arrowhead Pharmaceuticals is to provide new treatment options for patients suffering from genetic disorders, leveraging their expertise and partnerships to bring these therapies to market.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's collaboration with Sarepta Therapeutics brings significant financial and research opportunities.
  • The new obesity program could offer a gentler alternative to existing treatments.
  • Phase 2 data for plozasiran shows promising results for severe hypertriglyceridemia treatment.

What critics are saying

  • Regulatory approval is uncertain for RNAi-based therapies, impacting market entry timelines.
  • Dependence on partnerships may affect revenue stability if collaborations falter.
  • The competitive biotech landscape poses challenges for Arrowhead's market positioning.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi technology for gene silencing, targeting severe genetic diseases.
  • The company has a broad portfolio of RNA chemistries for efficient gene knockdown.
  • Arrowhead's strategic partnerships enhance its drug discovery and development capabilities.

Help us improve and share your feedback! Did you find this helpful?